Does Wegovy need to be at room temperature before you inject it?

Wegovy pens are stored refrigerated (2–8°C) but can be used directly from the fridge without warming first.
Leaving a pen out for up to 30 minutes before injecting is widely reported to ease injection comfort — check the Patient Information Leaflet for the exact room-temperature window permitted for your pen.
Once a pen has been left at room temperature, do not return it to the fridge, follow the time limit in your leaflet precisely.
Never warm a Wegovy pen in hot water, a microwave, or direct sunlight; only natural, passive warming at room temperature is appropriate.

Wegovy pens are stored in the fridge, but you do not need to bring the pen to room temperature before injecting. The manufacturer's guidance and the NHS semaglutide medicines page confirm that Wegovy can be injected straight from the fridge if needed — though many people find a cold pen slightly less comfortable at the injection site. This is a practical preference, not a clinical requirement. These pens contain semaglutide, a prescription-only medicine prescribed only after a clinical assessment confirms it is suitable for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and official guidance say about Wegovy injection temperature

Can you inject Wegovy straight from the fridge?

Yes. The Wegovy pre-filled pen is designed to be used from refrigerated storage and does not require warming before use. This distinguishes it from some older injectable medicines where room-temperature warming was mandatory. If you have just arrived home to your plain, tracked DPD delivery, taken the pen from the cool-pack and want to use it that day, you can do so immediately.

That said, a pen that has been sitting at 2°C will feel noticeably cooler against the skin, and some people report a brief stinging sensation when injecting cold liquid into the abdomen, thigh or upper arm. This is not harmful, but it is real. Letting the pen sit passively on a clean surface for around 20 to 30 minutes before use tends to reduce that sensation for most people. The key word is passively: no hot water bath, no microwave, no radiator. These methods heat unevenly and can degrade the medicine.

For everything relating to how long Wegovy can safely stay at room temperature, the authoritative source is your pen's Patient Information Leaflet, which sets out the precise time window for your specific product version. That figure takes precedence over any general statement you may read online.

Does the temperature of the pen affect how well Wegovy works?

There is no clinical evidence that injecting a cool pen produces a different pharmacological effect to injecting one at ambient temperature. The active ingredient, semaglutide, is absorbed subcutaneously regardless of whether the liquid is 4°C or 20°C when it enters the tissue. So warming the pen is entirely about your comfort during the injection, not about efficacy.

What does affect the medicine is sustained exposure to temperatures outside the permitted range: heat above 30°C, freezing, or direct sunlight. A pen that has been left in a car on a warm day or accidentally placed in the freezer compartment should not be used. If you are unsure whether a pen has been stored correctly, the guidance on Wegovy expiry and storage integrity covers what to look for and when to contact your pharmacy.

More detail on safe temperature requirements for storing Wegovy is set out in a dedicated page if you want to go deeper on the refrigeration rules.

What is the right way to warm a Wegovy pen before injecting?

Passive warming at room temperature is the only appropriate method. Remove the pen from the fridge, place it on a clean, dry surface away from heat sources or sunlight, and wait. That is the entirety of the guidance. Twenty to thirty minutes is the range most commonly cited by Novo Nordisk in patient-facing materials, but your specific leaflet sets the exact permitted window, and once that window closes, the pen should be used or discarded, not returned to cold storage.

A question our prescribers hear fairly often is whether holding the pen in your hand for a few minutes counts as warming. Gentle hand-warming is unlikely to cause any harm, but it is not controlled enough to rely on, and it is not what the leaflet describes. Sticking to passive room-temperature rest keeps things straightforward and consistent.

If side effects after injecting (such as nausea, fatigue or dizziness) are a concern for you, those are covered separately on the page about fatigue and post-injection symptoms. Temperature of the pen is not linked to those effects.

Does this guidance apply to all semaglutide pens, including Ozempic?

Semaglutide is used in more than one product. Ozempic contains semaglutide but is licensed for type 2 diabetes, not for weight management, they are different products with different licensed uses, even though the active molecule is the same. The storage and pre-injection temperature principles are broadly similar across semaglutide pens, but you should always follow the specific leaflet for the product you have been prescribed, as pen mechanisms, dose volumes and approved storage windows can differ between products and formulations.

Wegovy itself now comes in more than one pen format following the MHRA's approval of the higher 7.2mg single-dose pen in April 2026. Novo Nordisk's leaflet for each format sets its own permitted out-of-fridge window. If you are unsure which format you have or what rules apply to it, your prescriber is the right person to ask, and you can also check the guidance on whether semaglutide can be kept at room temperature for a broader look at how the rules work across formats. For a full overview of the Wegovy treatment itself, the Wegovy treatment page covers eligibility, how it works and how to access it through a regulated UK pharmacy.

If you are considering starting Wegovy and want a clinical assessment from a GPhC-registered prescriber, speak to our prescribers through a free consultation, reviewed the same day, with no waiting list.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions